$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000162828017008014 Filed on August 03, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$4.265M	$1.900M
YoY Change	124.47%	26.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.058M	$3.739M
YoY Change	-18.21%	43.53%
% of Gross Profit
Research & Development	$5.068M	$2.948M
YoY Change	71.91%	-0.37%
% of Gross Profit
Depreciation & Amortization	$39.66K	$43.59K
YoY Change	-9.01%	-35.97%
% of Gross Profit
Operating Expenses	$8.323M	$11.19M
YoY Change	-25.6%	92.86%
Operating Profit	-$4.059M	-$9.285M
YoY Change	-56.28%	114.34%
Interest Expense	$3.652M	$10.21K
YoY Change	35659.7%	-23.29%
% of Operating Profit
Other Income/Expense, Net	$8.066K	$58.49K
YoY Change	-86.21%	437.73%
Pretax Income	$7.400M	$9.600M
YoY Change	-22.92%	47.69%
Income Tax	$92.83K	$1.470K
% Of Pretax Income	1.25%	0.02%
Net Earnings	-$7.501M	-$9.566M
YoY Change	-21.59%	45.53%
Net Earnings / Revenue	-175.87%	-503.47%
Basic Earnings Per Share
Diluted Earnings Per Share	-$95.18K	-$177.1K
COMMON SHARES
Basic Shares Outstanding	78.78M shares	54.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.90M	$78.00M
YoY Change	-60.38%	-32.58%
Cash & Equivalents	$30.87M	$78.02M
Short-Term Investments
Other Short-Term Assets	$10.90M	$2.100M
YoY Change	419.05%	-73.75%
Inventory	$15.42M	$28.93M
Prepaid Expenses
Receivables	$1.769M	$34.49M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$58.95M	$143.6M
YoY Change	-58.94%	7.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$263.0K	$372.8K
YoY Change	-29.46%	-16.53%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$642.1K	$641.6K
YoY Change	0.08%	-67.75%
Total Long-Term Assets	$97.08M	$58.10M
YoY Change	67.1%	17.87%
TOTAL ASSETS
Total Short-Term Assets	$58.95M	$143.6M
Total Long-Term Assets	$97.08M	$58.10M
Total Assets	$156.0M	$201.7M
YoY Change	-22.63%	10.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.475M	$9.917M
YoY Change	-64.96%	107.44%
Accrued Expenses	$3.098M	$3.311M
YoY Change	-6.43%	2.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.63M	$216.9M
YoY Change	-93.71%	2603.02%
LONG-TERM LIABILITIES
Long-Term Debt	$68.80M	$0.00
YoY Change
Other Long-Term Liabilities	$376.7M	$288.6M
YoY Change	30.53%	-32.38%
Total Long-Term Liabilities	$445.5M	$288.6M
YoY Change	54.37%	-32.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.63M	$216.9M
Total Long-Term Liabilities	$445.5M	$288.6M
Total Liabilities	$459.4M	$505.7M
YoY Change	-9.16%	14.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$517.3M	-$481.5M
YoY Change	7.44%	10.5%
Common Stock	$213.8M	$177.4M
YoY Change	20.56%	0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$303.4M	-$304.1M
YoY Change
Total Liabilities & Shareholders Equity	$156.0M	$201.7M
YoY Change	-22.63%	10.53%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$7.501M	-$9.566M
YoY Change	-21.59%	45.53%
Depreciation, Depletion And Amortization	$39.66K	$43.59K
YoY Change	-9.01%	-35.97%
Cash From Operating Activities	-$1.680M	-$26.04M
YoY Change	-93.55%	-229.55%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$40.00K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-60.00K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-1.680M	-26.04M
Cash From Investing Activities	-40.00K	0.000
Cash From Financing Activities	-60.00K	0.000
Net Change In Cash	-1.780M	-26.04M
YoY Change	-93.16%	-229.49%
FREE CASH FLOW
Cash From Operating Activities	-$1.680M	-$26.04M
Capital Expenditures	-$40.00K	$0.00
Free Cash Flow	-$1.640M	-$26.04M
YoY Change	-93.7%	-229.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78908929	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Trading Symbol TradingSymbol	SIGAQ
CY2011Q2	siga	Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry	50000000	USD
CY2016Q4	siga	Computer Equipment ComputerEquipment	770479	USD
CY2017Q2	siga	Computer Equipment ComputerEquipment	774344	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2011Q2	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	122700000	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	0	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-331853	USD
CY2016Q2	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
CY2017Q2	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	-294356	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	331853	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	203654855	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	0	USD
CY2017Q1	siga	Increaseto Fundingof Researchand Development Contract IncreasetoFundingofResearchandDevelopmentContract	10100000	USD
	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	0	USD
	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	5058533	USD
	siga	Inventory Write Downs InventoryWriteDowns	686000	USD
	siga	Number Of Active Grants NumberOfActiveGrants	1	grant
CY2017Q2	siga	Numberof Coursestobe Deliveredby Company NumberofCoursestobeDeliveredbyCompany	338000	course
CY2016Q2	siga	Patent Preparation Fees PatentPreparationFees	239690	USD
	siga	Patent Preparation Fees PatentPreparationFees	459405	USD
CY2017Q2	siga	Patent Preparation Fees PatentPreparationFees	197017	USD
	siga	Patent Preparation Fees PatentPreparationFees	437615	USD
	siga	Paymentof Interest Expense PaymentofInterestExpense	0	USD
	siga	Paymentof Interest Expense PaymentofInterestExpense	-5058533	USD
CY2017Q2	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	16200000	USD
CY2016	siga	Reducedholdbackamount Reducedholdbackamount	40900000	USD
CY2016Q2	siga	Reorganization Payments ReorganizationPayments	809000	USD
	siga	Reorganization Payments ReorganizationPayments	2300000	USD
CY2016Q2	siga	Reorganization Professional Fees ReorganizationProfessionalFees	34293	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1732521	USD
CY2016Q2	siga	Reorganization Trusteefees ReorganizationTrusteefees	20000	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	33000	USD
CY2016Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1901314	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	3171047	USD
CY2017Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4264561	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	9466347	USD
CY2017Q2	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	3000000	USD
	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	7600000	USD
	siga	Restricted Stock Units RestrictedStockUnits	363337	shares
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2517072	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3475102	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3154370	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1768981	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2357194	USD
CY2017Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1191940	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4584752	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3097915	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	481641	USD
CY2017Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	520923	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	262664	USD
CY2017Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	337020	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3468266	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3508642	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213714154	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213838069	USD
CY2016Q4	us-gaap	Assets Assets	160981977	USD
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78692612	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78908929	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78692612	shares
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2017Q2	us-gaap	Assets Assets	156030474	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	69159474	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	58945660	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78022356	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28701824	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30865936	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-34688672	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2164112	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.29
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78908929	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	7869	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	7891	USD
CY2017Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	92825	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	207895	USD
CY2016Q2	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	273436	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1951381	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	72649277	USD
CY2017Q2	us-gaap	Deferred Costs DeferredCosts	83190032	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33035036	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8996221	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	367483905	USD
CY2017Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	376480126	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	286066	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	307256	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43592	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88044	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39663	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75837	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	331853000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6727409000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7059262000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5894550	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-528807	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30812004	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1385389	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	3252176	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	10540755	USD
CY2017Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2016Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q2	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	7400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	15900000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9564381	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20001654	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7408612	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15908489	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1470	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12764	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92825	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	207895	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11445	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21190	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16484805	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10257156	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1347956	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-42114	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-9666	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1500309	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-382780	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	10214	USD
	us-gaap	Interest Expense InterestExpense	10214	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	3652496	USD
	us-gaap	Interest Expense InterestExpense	7261412	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7293880	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3862429	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	26209964	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	15416808	USD
CY2016Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	18916084	USD
CY2017Q2	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	11554379	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	536000	USD
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2017Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2016Q4	us-gaap	Liabilities Liabilities	448400246	USD
CY2017Q2	us-gaap	Liabilities Liabilities	459441190	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160981977	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	156030474	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13829233	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	13632279	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	-206972170	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	0	USD
CY2016Q2	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	4259451	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	7176637	USD
CY2017Q2	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	66553053	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	68783206	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-249555	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10998	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39326	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34677674	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2452993	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-9565851	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20014418	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-7501437	USD
	us-gaap	Net Income Loss NetIncomeLoss	-16116384	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	58489	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69800	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8066	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12484	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	11186241	USD
	us-gaap	Operating Expenses OperatingExpenses	19515385	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	8323099	USD
	us-gaap	Operating Expenses OperatingExpenses	17794055	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9284927	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16344338	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4058538	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8327708	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1483253	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1048032	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	247989	USD
CY2017Q2	us-gaap	Other Liabilities OtherLiabilities	238323	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	2230154	USD
CY2016Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	217000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	84000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	193052	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10998	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39326	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	954426	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	571646	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27497	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3767743	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3771608	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299477	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	262966	USD
CY2016Q2	us-gaap	Reorganization Items ReorganizationItems	327729	USD
	us-gaap	Reorganization Items ReorganizationItems	3716902	USD
CY2017Q2	us-gaap	Reorganization Items ReorganizationItems	0	USD
	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2948391	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5484403	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5067838	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11428327	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10138890	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10322289	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17333332	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	12091399	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-501140292	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-517256676	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3738709	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6394940	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3058244	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5928113	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	368436	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	373492	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-287418269	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	-303410716	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6727409	USD
CY2017Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7059262	USD
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54216604	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54165450	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78840312	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78808903	shares

Files In Submission

Name	View Source	Status
0001628280-17-008014-index-headers.html	Edgar Link	pending
0001628280-17-008014-index.html	Edgar Link	pending
0001628280-17-008014.txt	Edgar Link	pending
0001628280-17-008014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20170630.xml	Edgar Link	completed
siga-20170630.xsd	Edgar Link	pending
siga-20170630x10q.htm	Edgar Link	pending
siga-20170630_cal.xml	Edgar Link	unprocessable
siga-20170630_def.xml	Edgar Link	unprocessable
siga-20170630_lab.xml	Edgar Link	unprocessable
siga-20170630_pre.xml	Edgar Link	unprocessable
siga-exhibit1022017q2.htm	Edgar Link	pending
siga-exhibit3112017q2.htm	Edgar Link	pending
siga-exhibit3122017q2.htm	Edgar Link	pending
siga-exhibit3212017q2.htm	Edgar Link	pending
siga-exhibit3222017q2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2017 Q2 Form 10-Q Financial Statement

#000162828017008014 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2017 Q2 Form 10-Q Financial Statement

#000162828017008014 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga